Fortis Group Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
245
+15
+7% +$1.21K ﹤0.01% 347
2026
Q1
$19.9K Hold
230
﹤0.01% 344
2025
Q4
$22.1K Hold
230
﹤0.01% 333
2025
Q3
$21.9K Hold
230
﹤0.01% 289
2025
Q2
$20K Hold
230
﹤0.01% 289
2025
Q1
$20.7K Hold
230
﹤0.01% 252
2024
Q4
$18.4K Hold
230
﹤0.01% 264
2024
Q3
$20.7K Hold
230
﹤0.01% 240
2024
Q2
$18.1K Hold
230
﹤0.01% 244
2024
Q1
$20K Sell
230
-230
-50% -$19.6K ﹤0.01% 260
2023
Q4
$37.9K Buy
460
+230
+100% +$17.5K 0.01% 184
2023
Q3
$18K Buy
+230
New +$19.3K 0.01% 182
2020
Q3
$395K Buy
+3,808
New +$382K 0.08% 121

Other funds holding MDT

Fortis Group Advisors's MDT Position: Q2 2026 in Review

Fortis Group Advisors increased its Medtronic (MDT) stake by 6.5% in Q2 2026, buying an estimated $1.21K and bringing the position to 245 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Fortis Group Advisors first reported a position in MDT in Q3 2020 and has held it in 13 quarters since. The position peaked at $395K in Q3 2020. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fortis Group Advisors held 245 shares of Medtronic worth $19.2K as of Q2 2026.
  • Fortis Group Advisors bought 15 Medtronic shares in Q2 2026, an estimated $1.21K.
  • Medtronic made up ﹤0.01% of Fortis Group Advisors's portfolio in Q2 2026, its #347 holding.
  • Fortis Group Advisors first reported a position in Medtronic in Q3 2020 and has held it in 13 quarters since.
  • Fortis Group Advisors's Medtronic position peaked at $395K in Q3 2020.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.